Project TitleProduction of Cholinergic Neurons From Stem Cells
Track Code2009-173
Short Description

Novel method for generating functional human cholinergic neurons from stem cells

#researchtool #CNS #Alzheimersdisease


Northwestern researchers have developed a method to generate fully functional human basal forebrain cholinergic neurons (BFCNs) from stem cells, which holds promise for Alzheimer's Disease (AD) therapy. The loss of BFCNs occurs in the early stages of disease, and it is believed that reversing this process could be essential to developing a viable treatment strategy. The BFCNs generated in Prof. Kessler's laboratory have relevant markers of cholinergic neurons and can be generated to a high purity of up to 94%. These cells also integrate into functional synapses in mouse brain tissue, opening up the possibility that the same could be achieved in humans with patient-derived BFCNs. In addition, this invention could be used in pharmacological studies for identification of new Alzheimer's drugs or for studying their mode of action.

TagsCNS: Alzheimer's Disease, research tool
Posted DateJun 3, 2015 3:49 PM


Christopher Bissonnette

John Kessler*


  • Treatment for Alzheimer’s Disease
  • Drug screening
  • Pharmacological studies


  • Non- pharmacologic alternative for Alzheimer’s Disease treatment


IP Status

Issued US patent 8,796, 022

Contact Information

Michael Moore, PhD

Invention Manager

(p) 847.491.4645